Elanco Animal Health IncorporatedELANNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -1.45% | -1.00% | +4.81% | +10.39% | +12.16% |
| Gross Profit Growth | +2.10% | -0.18% | +3.41% | +49.88% | +15.68% |
| EBITDA Growth | +57.66% | +12.30% | +35.38% | -78.13% | -96.57% |
| Operating Income Growth | -20.00% | -9.02% | -26.09% | +0.00% | +137.50% |
| Net Income Growth | +0.00% | +109.38% | +0.00% | -109.34% | +0.00% |
| EPS Growth | +0.00% | +115.72% | +0.00% | -109.46% | +0.00% |
| EPS Diluted Growth | +0.00% | +101.55% | +0.00% | -109.59% | +0.00% |
| Weighted Average Shares Growth | +0.32% | +0.39% | +0.49% | +0.51% | +0.51% |
| Weighted Average Shares Diluted Growth | +0.32% | +0.63% | +1.19% | -0.18% | +0.51% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +12.74% | -300.00% | +18.50% | +35.19% | -38.98% |
| Free Cash Flow Growth | +6.90% | +0.00% | +8.43% | +5.83% | -62.90% |
| Receivables Growth | -12.28% | -1.67% | +2.13% | +7.85% | +6.09% |
| Inventory Growth | -9.28% | -2.81% | +3.66% | +4.66% | +10.36% |
| Asset Growth | -12.17% | -7.69% | -0.16% | +2.02% | +5.90% |
| Book Value per Share Growth | -2.36% | +4.50% | +13.47% | +2.94% | +6.86% |
| Debt Growth | -25.16% | -23.76% | -25.85% | -7.64% | -7.04% |
| R&D Expense Growth | +2.53% | +8.05% | +3.37% | +2.30% | +14.81% |
| SG&A Expenses Growth | +2.74% | +1.19% | +12.99% | +8.67% | +12.67% |